Yahoo
Oslo - Delayed Quote NOK

Lifecare ASA (LIFE.OL)

0.4360 +0.0090 (+2.11%)
At close: October 30 at 4:25:20 PM GMT+1
Chart Range Bar
Loading chart for LIFE.OL
  • Previous Close 0.4270
  • Open 0.4335
  • Bid 0.4130 x --
  • Ask 0.4450 x --
  • Day's Range 0.4280 - 0.4800
  • 52 Week Range 0.2700 - 6.1000
  • Volume 5,445,290
  • Avg. Volume 9,462,397
  • Market Cap (intraday) 187.637M
  • Beta (5Y Monthly) -0.75
  • PE Ratio (TTM) --
  • EPS (TTM) -1.6900
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 0.40

Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway and United Kingdom. The company develops Sencell, a 3D printed nano-sensor for monitoring glucose levels in patients with diabetes and for veterinary applications; as well as medical devices that remove subdermal implants. Lifecare ASA was founded in 2006 and is headquartered in Bergen, Norway.

lifecare.no

11

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

LIFE.OL
61.64%
MSCI WORLD (^990100-USD-STRD)
9.06%

1-Year Return

LIFE.OL
92.13%
MSCI WORLD (^990100-USD-STRD)
9.89%

3-Year Return

LIFE.OL
98.41%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

LIFE.OL
97.86%
MSCI WORLD (^990100-USD-STRD)
53.16%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY23
Revenue 5.15M
Earnings --
Profit Margin 0.00%

Q2

FY23

Q3

FY23

Q4

FY23

-5M
0
5M
-250.0%
-200.0%
-150.0%
-100.0%
-50.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

0.40 Low
0.40 Average
0.4360 Current
0.40

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -101.03%

  • Return on Equity (ttm)

    -208.68%

  • Revenue (ttm)

    7.67M

  • Net Income Avi to Common (ttm)

    -117.81M

  • Diluted EPS (ttm)

    -1.6900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    36.84M

  • Total Debt/Equity (mrq)

    10.10%

  • Levered Free Cash Flow (ttm)

    -74.94M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: